从India供应商批发进口Albaquin — FOB条款

Albaquin is a topical depigmentation cream formulated with Monobenzone as the active pharmaceutical ingredient, manufactured by Puneet Laboratories Pvt. Ltd. in Mumbai, Maharashtra, India. The product is supplied in bulk pharmaceutical-grade batches for export to distributors and importers serving hospital pharmacies, dermatology clinics, and regulated clinical beauty sectors. Monobenzone works by irreversibly destroying melanocytes, permanently removing pigment from surrounding unaffected skin to achieve uniform colouration in patients with generalised vitiligo where depigmentation represents the sole viable therapeutic endpoint.

The cream base is a water-based emulsion designed for topical application under strict medical supervision, with standard pharmaceutical packaging in jars and tubes suitable for clinical dispensing. Monobenzone concentration in commercially available formulations typically ranges from 20% w/w as the standard clinical strength, though the exact concentration and excipient profile for Puneet Laboratories' specific batches must be confirmed directly with the supplier. The mechanism of action involves selective melanocyte destruction through quinone generation and free radical damage, which is fundamentally distinct from reversible tyrosinase inhibitors used for hyperpigmentation disorders. Regulatory classification varies by jurisdiction: Monobenzone products may be prescription-only medicines, pharmacy-only, or subject to controlled distribution depending on national pharmaceutical legislation.

Albaquin targets importers and distributors in the pharmaceutical and clinical dermatology sectors, particularly those supplying hospital pharmacies and specialist clinics managing extensive or advanced generalised vitiligo. The product is not indicated for hyperpigmentation from other causes, including post-inflammatory hyperpigmentation, melasma, or solar lentigines, as these conditions require melanocyte-preserving rather than melanocyte-destructive approaches. Buyers should confirm with Puneet Laboratories the specific Monobenzone assay percentage, complete qualitative and quantitative composition, stability data, and whether the manufacturing site holds current WHO-GMP, EU-GMP, or equivalent national GMP certification for export to regulated markets.

Puneet Laboratories Pvt. Ltd. is headquartered at 605 Raheja Plaza-B on L.B.S. Marg in Ghatkopar (West), Mumbai 400086, Maharashtra, India, placing the company within Mumbai's established pharmaceutical manufacturing and distribution corridor. The supplier holds a Harbor trust tier, though the response rate is recorded at 0.00% with zero average response hours, suggesting that platform-mediated communication may not be the primary channel for commercial enquiries. The company's specialisation centres on dermatological and pharmaceutical formulations, with Albaquin representing a niche but clinically significant product for vitiligo management.

The listing does not disclose manufacturing facility ownership, whether production occurs at the Mumbai address or at a separate GMP-certified site, annual production capacity for Monobenzone formulations, other products in the portfolio, or specific international regulatory accreditations held. No information is provided about in-house quality control capabilities, stability testing infrastructure, or pharmacovigilance systems. Buyers should independently verify current GMP certification status, whether the facility has undergone recent regulatory inspection by CDSCO, FDA, EMA, or other competent authority, and the company's experience with export documentation and cold-chain or controlled-temperature logistics if required.